Operating Lease, Liability in USD of Can-Fite BioPharma Ltd. from Q4 2019 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Can-Fite BioPharma Ltd. quarterly Operating Lease, Liability history and change rate from Q4 2019 to Q4 2024.
Can-Fite BioPharma Ltd. Operating Lease, Liability for the quarter ending 31 Dec 2024 was $104K, a 160% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$104K	+$64K	+160%	31 Dec 2024	20-F	14 Apr 2025
Q4 2023	$40K	-$22K	-35.5%	31 Dec 2023	20-F	28 Mar 2024
Q4 2022	$62K	-$62K	-50%	31 Dec 2022	20-F	30 Mar 2023
Q4 2021	$124K	+$57K	+85.1%	31 Dec 2021	20-F	24 Mar 2022
Q4 2020	$67K	-$8K	-10.7%	31 Dec 2020	20-F	25 Mar 2021
Q4 2019	$75K			31 Dec 2019	6-K	01 Jun 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.